Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | TLR8 | Q9NR97 | 2/20 | 0.41 |
| ▸ | TYR | P14679 | 1/20 | 0.39 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.39 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.39 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.38 |
| ▸ | CTRC | Q99895 | 1/20 | 0.36 |
| ▸ | BID | P55957 | 3/20 | 0.36 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.36 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.36 |
| ▸ | BAK1 | Q16611 | 2/20 | 0.36 |
| ▸ | KAT8 | Q9H7Z6 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2971160 | 0.93 | LIPG (0.55) | LIPGTLR8NR1H2NR1H3ALOX5 | |
| SCHEMBL2969852 | 0.91 | LIPG (0.58) | LIPGCYP3A4TYRNR1H2NR1H3 | |
| SCHEMBL139633 | 0.86 | LIPG (0.36) | LIPG | |
| SCHEMBL29520482 | 0.83 | LIPG (0.56) | LIPGCYP3A4CYP2D6CYP2C9TLR8 | |
| SCHEMBL245188 | 0.83 | LIPG (0.56) | LIPGCYP3A4CYP2D6CYP2C9TLR8 | |
| SCHEMBL2049761 | 0.80 | LIPG (0.54) | LIPGCYP3A4CYP2D6CYP2C9TLR8 | |
| Ammonia Solution, Strong SCHEMBL28991000 | 0.80 | LIPG (0.54) | LIPGCYP3A4CYP2D6CYP2C9TLR8 | |
| Benzene SCHEMBL3118223 | 0.80 | LIPG (0.54) | LIPGCYP3A4CYP2D6CYP2C9TLR8 | |
| SCHEMBL29414141 | 0.80 | LIPG (0.54) | LIPGCYP3A4CYP2D6CYP2C9TLR8 | |
| Hydrogen Sulfide SCHEMBL28851632 | 0.80 | LIPG (0.54) | LIPGCYP3A4CYP2D6CYP2C9TLR8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7770534-B2 | Changed condition indicator | THERMOPROX | 2010-08-10 | — | — | US | disclosed |
| US-7763562-B2 | Heteroatom bridged metallocene compounds for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2010-07-27 | — | — | US | disclosed |
| US-20070151502-A1 | Changed condition indicator | THERMOPROX | 2007-07-05 | — | — | US | disclosed |
| US-20070135597-A1 | Heteroatom bridged metallocene compounds for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2007-06-14 | — | — | US | disclosed |
| US-6984722-B2 | Cationic group 3 catalyst system | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2006-01-10 | — | — | US | disclosed |
| US-6677441-B2 | CATIONIC GROUP 3 OR LANTHANIDE METAL COMPLEX STABILIZED BY A MONOANIONIC BIDENTATE ANCILLARY LIGAND AND TWO MONOANIONIC LIGANDS; COORDINATION POLYMERIZATION OF OLEFINS | EXXONMOBIL CHEMICAL PATENTS INC. | 2004-01-13 | — | — | US | disclosed |
| US-6403773-B1 | GROUP 3 OR LANTHANIDE METAL COMPLEX WHICH FORMS ACTIVE CATIONIC CATALYST SPECIES FOR PRODUCTION OF POLYOLEFINS HAVING HIGH MOLECULAR WEIGHT | EXXON MOBIL CHEMICAL PATENTS INC. | 2002-06-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070135597-A1 | Heteroatom bridged metallocene compounds for olefin polymerization | AP2M1, AP1M1, PYM1 | LIPG 3839/4885CYP3A4 1385/4885CYP2D6 2519/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.